Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
THAP domain containing 12 pseudogene 4 (THAP12P4) is a human pseudogene, meaning it resembles a protein-coding gene but is generally considered non-functional due to accumulated mutations or lack of expression. It is listed in genetic databases under identifiers such as HGNC: 39568 and NCBI Gene: 100129382[3]. There is no evidence that THAP12P4 encodes a protein, nor is it associated with known molecular functions, biological processes, or therapeutic targeting. It is important not to confuse THAP12P4 with its parent or related gene, THAP domain containing 12 (THAP12), which is a protein-coding gene involved in DNA binding and cellular growth regulation[4][6]. The pseudogene designation and absence of functional annotation mean THAP12P4 is not a receptor, enzyme, or other validated biological target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on THAP domain containing 12 pseudogene 4 (THAP12P4).